LoginSignup
TMO

Thermo Fisher Canadian Hedged Depositary Receipts

Stock
Stock
ISIN: CA88355G1000
Ticker: TMO
CA88355G1000
TMO

Price

Price

Historical dividends and forecast

All dividend data

Thermo Fisher Canadian Hedged Depositary Receipts has so far distributed 0.032 in 2024. The next dividend will be paid on 22.01.2025

0.0316

CHART BY

Frequently asked questions

What is Thermo Fisher Canadian Hedged Depositary Receipts's market capitalization?

The market capitalization of Thermo Fisher Canadian Hedged Depositary Receipts is $196.16B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Thermo Fisher Canadian Hedged Depositary Receipts's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Thermo Fisher Canadian Hedged Depositary Receipts is 32.16. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Thermo Fisher Canadian Hedged Depositary Receipts?

Thermo Fisher Canadian Hedged Depositary Receipts's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 15.95. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Thermo Fisher Canadian Hedged Depositary Receipts's stock?

Currently, 25 analysts cover Thermo Fisher Canadian Hedged Depositary Receipts's stock, with a consensus target price of $625.37. Analyst ratings provide insights into the stock's expected performance.

What is Thermo Fisher Canadian Hedged Depositary Receipts's revenue over the trailing twelve months?

Over the trailing twelve months, Thermo Fisher Canadian Hedged Depositary Receipts reported a revenue of $42.37B.

Is Thermo Fisher Canadian Hedged Depositary Receipts paying dividends?

Yes, Thermo Fisher Canadian Hedged Depositary Receipts is paying dividends. The next payment is scheduled for 22.01.2025, with an expected amount of .

What is the EBITDA for Thermo Fisher Canadian Hedged Depositary Receipts?

Thermo Fisher Canadian Hedged Depositary Receipts's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $10.67B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Thermo Fisher Canadian Hedged Depositary Receipts?

Thermo Fisher Canadian Hedged Depositary Receipts has a free cash flow of $7.21B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Thermo Fisher Canadian Hedged Depositary Receipts's stock?

The 5-year beta for Thermo Fisher Canadian Hedged Depositary Receipts is 0.78. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Thermo Fisher Canadian Hedged Depositary Receipts have, and what sector and industry does it belong to?

Thermo Fisher Canadian Hedged Depositary Receipts employs approximately 122,000 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Thermo Fisher Canadian Hedged Depositary Receipts's shares?

The free float of Thermo Fisher Canadian Hedged Depositary Receipts is 381.81M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $196.16B

5Y beta

 0.78

EPS (TTM)

 15.95

Free Float

 381.81M

P/E ratio (TTM)

 32.16

Revenue (TTM)

 $42.37B

EBITDA (TTM)

 $10.67B

Free Cashflow (TTM)

 $7.21B

Analyst Ratings

The price target is $625.37 and the stock is covered by 25 analysts.

Buy

17

Hold

8

Sell

0

Information

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

122,000

Medical Equipment & Supplies

Health Care

Identifier

ISIN

CA88355G1000

Primary Ticker

TMO

Knockouts

Join the conversation
Sign upLogin